Pharmacogenetic labyrinth of neovascular age-related macular degeneration therapy: how to escape and move forward?

Pharmacogenomics. 2013 Aug;14(11):1239-42. doi: 10.2217/pgs.13.100.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Macular Degeneration / drug therapy*
  • Macular Degeneration / pathology
  • Pharmacogenetics*
  • Porphyrins / therapeutic use
  • Precision Medicine*
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vascular Endothelial Growth Factor A / therapeutic use
  • Verteporfin

Substances

  • Porphyrins
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Verteporfin